Clinical trials: Patient With Atrial Fibrillation or High Stroke Risk
Atrial Fibrillation/Flutter in Patients With High Risk of Stroke
A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke
The purpose of this study is to evaluate the benefits in the atrial fibrillation detection rate of the continuous ECG monitoring group for more than 8 days by contrasting with one-day ECG monitoring using MEMO Patch PLUS in 1000…
- Trial name
- MEMO-DAF8 (NCT05355948)
- Testing
- MEMO Patch PLUS for 1 day, MEMO Patch PLUS for More than 8-days
- Where
- South Korea
- Volunteers
- 1,000 people
- Sponsor
- Yonsei University
Atrial Fibrillation, Stroke
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
Atrial fibrillation (AF) is the most preventable cause of stroke. CHADS and CHA2DS2VASc scores predict the likelihood of stroke in patients with nonvalvular AF.
- Trial name
- AF-ALERT (NCT02339493)
- Testing
- Computer Electronic Alert
- Where
- United States
- Volunteers
- 458 people
- Sponsor
- Brigham and Women's Hospital
Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
There has no evidence for the anticoagulation in patients who had undergone catheter ablation of atrial fibrillation, and has maintained sinus rhythm for more than 1 year.
- Trial name
- NCT04432220
- Testing
- Anticoagulation group(Apixaban group)
- Where
- South Korea
- Volunteers
- 840 people
- Sponsor
- Yonsei University
Patient With Atrial Fibrillation or High Stroke Risk
Continuous EKG Monitoring Using S-Patch Ex : Prospective Observational Study (S-patch Registry)
Atrial fibrillation (AF) is associated with increased mortality and morbidity, and is a dominant, yet preventable, cause of cardioembolic stroke, which has more severe outcomes than other ischaemic stroke causes if left…
- Trial name
- NCT05119725
- Testing
- continous 3 day EKG monitoring with S-Patch Cardio
- Where
- South Korea
- Volunteers
- 2,450 people
- Sponsor
- Yonsei University